UBC PiMS Research Group (the Tremlett Laboratory)
Pharmacoepidemiology in Multiple Sclerosis Research Group (the Tremlett Laboratory)


ACTRIMS, Florida, 02/2022.

The gut microbe in pediatric-onset MS: a matched case-control study.

Authors: X. Zhou, M. Horton, K. Mccauley, L. Krupp, J. Tillema, M. P. Gorman, L. Benson, J. Ness, B. Weinstock- Guttman, A. T. Waldman, J. Hart, T. Casper, S. Lynch, H. Tremlett, E. Waubant, on behalf of the US network of pediatric MS centers.

Presentation Type: Platform (oral)

Disease-modifying drug uptake and health service use in the ageing MS population.

Authors: H.S. Ng, J. Graf, F. Zhu, E. Kingswell, O. Aktas, P. Albrecht, H.P. Hartung, S.G. Meuth, C. Evans, J.D. Fisk, R.A. Marrie, Y. Zhao, H. Tremlett.

Presentation Type: Poster

Abstract Number: 217. Poster Number: P188. Poster Session: PS1.
Dr Graf awarded: $US 600 Educational Grant from the ACTRIMS Forum 2022 Program Committee to attend the meeting in person (declined due to the COVID19 pandemic)

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia